NCT05924269View on ClinicalTrials.gov

Role of Neuronal Guidance Proteins as Diagnostic Markers for Acute Kidney Injury (AKI)

Not yet recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Acute Kidney Injury

All Listed Sponsors

lead

University Hospital Tuebingen

OTHER

NCT05924269 - Role of Neuronal Guidance Proteins as Diagnostic Markers for Acute Kidney Injury (AKI) | Biotech Hunter | Biotech Hunter